ZBH
47
2
SJM
16
2
FOX
70
2
BDX
61
2
PVH
32
2
VZ
42
3
DG
72
4
NKE
39
3
HAS
68
2
FMC
16
6
BWA
55
2
AXP
71
-2
NEE
54
2
AES
57
2
AKAM
59
-2
HRL
36
-2
EBAY
56
2
CHRW
76
-3
ADI
73
-3
HCA
66
2
ZBH
47
2
SJM
16
2
FOX
70
2
BDX
61
2
PVH
32
2
VZ
42
3
DG
72
4
NKE
39
3
HAS
68
2
FMC
16
6
BWA
55
2
AXP
71
-2
NEE
54
2
AES
57
2
AKAM
59
-2
HRL
36
-2
EBAY
56
2
CHRW
76
-3
ADI
73
-3
HCA
66
2
Financhill
Back

Santen Pharmaceutical Co., Ltd. Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51

SNPHY
Santen Pharmaceutical Co., Ltd.

Last Price:
$10.58
Seasonality Move:
-2.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Santen Pharmaceutical Co., Ltd. Stock Forecast

  • Over the next 52 weeks, Santen Pharmaceutical Co., Ltd. has on average historically risen by 4.5% based on the past 14 years of stock performance.
  • Santen Pharmaceutical Co., Ltd. has risen higher in 9 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.29%
  • Is Santen Pharmaceutical Co., Ltd. Stock Undervalued?
    The current Santen Pharmaceutical Co., Ltd. [SNPHY] share price is $10.58. The Score for SNPHY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • SNPHY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Santen Pharmaceutical Co., Ltd. Stock Go Up Next Year?

  • Over the next 52 weeks, Santen Pharmaceutical Co., Ltd. has on average historically risen by 4.5% based on the past 14 years of stock performance.

Santen Pharmaceutical Co., Ltd. Stock Rating

Buy
51
Santen Pharmaceutical Co., Ltd. (SNPHY) is a Buy

Is Santen Pharmaceutical Co., Ltd. overpriced?

  • Santen Pharmaceutical Co., Ltd. has risen higher in 9 of those 14 years over the subsequent 52-week period, corresponding to a historical accuracy of 64.29%

Santen Pharmaceutical Co., Ltd. Stock Price History

Is SNPHY stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNPHY is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Japan
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
santen.co.jp

52-Week Data

52-Week High:
12.04
52-Week Low:
8.65

Prediction Charts

Market Cap:
3.4B
Price in USD:
10.58
Volume:
11.3K
Beta:
0.35

Technical Analysis

SMA50:
10.12
SMA100:
10.46
SMA200:
10.54
52-Wk Change:
6.57%

Stock Predictions

  • Is Santen Pharmaceutical Co., Ltd. stock public?
    Yes, Santen Pharmaceutical Co., Ltd. is a publicly traded company.
  • What is the Santen Pharmaceutical Co., Ltd. stock quote today?
    The Santen Pharmaceutical Co., Ltd. stock price is 10.58 USD today.
  • How to buy Santen Pharmaceutical Co., Ltd. stock online?
    You can buy Santen Pharmaceutical Co., Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-8 9.76 10.00 10.00 9.76
Dec-9 10.01 10.36 10.36 10.01
Dec-10 10.13 10.01 10.19 10.01
Dec-11 10.14 10.36 10.53 10.14
Dec-12 10.13 9.96 10.17 9.96
Dec-15 10.20 10.16 10.39 10.03
Dec-16 10.46 10.54 10.82 10.46
Dec-17 10.37 10.10 10.37 9.88
Dec-18 10.57 10.67 10.67 10.57
Dec-19 10.43 10.37 10.45 10.37
Dec-22 10.30 10.37 10.81 10.30
Dec-23 10.57 10.17 10.57 10.17
Dec-24 10.46 10.37 10.66 10.07
Dec-26 10.49 10.58 10.58 10.38

Santen Pharmaceutical Co., Ltd. Earnings

Data Unavailable

Santen Pharmaceutical Co., Ltd. Forecast Revenue Growth

Data Unavailable

* Santen Pharmaceutical Co., Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.